{
    "2019-05-23": [
        [
            {
                "time": "",
                "original_text": "【增减持】药明康德(02359.HK)获The Capital Group Companies增持7.09万股H股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "The Capital Group Companies",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中国医药行业研发专题分析报告:转型、创新、发展,中国医药研发蓬勃兴起,从2018年上市公司年报看国内医药研发",
                "features": {
                    "keywords": [
                        "中国医药行业",
                        "研发",
                        "转型",
                        "创新",
                        "发展",
                        "2018年上市公司年报"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}